Protagonist Therapeutics Inc (PTGX)
Company Info
Highlights
$2.30B
$2.74
14.06
$263.80M
$262.08M
$127.53M
$24.22 - $48.89
$58.40
6.45%
6.91
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Protagonist Therapeutics Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Protagonist Therapeutics Inc had a return of -0.18% year-to-date (YTD) and 41.50% in the last 12 months.
PTGX
-0.18%
4.64%
-7.27%
41.50%
33.73%
N/A
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of PTGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -2.07% | -0.18% | |||||||||||
| 2024 | 9.07% | 21.47% | -4.77% | -13.20% | 12.11% | 23.09% | 8.05% | 14.56% | 4.92% | 1.87% | -4.45% | -11.87% | 68.34% |
| 2023 | 21.81% | 22.05% | 41.80% | -1.74% | 15.35% | 5.95% | -29.76% | 2.16% | -15.84% | -12.83% | 25.24% | 25.92% | 110.17% |
| 2022 | -14.36% | -17.10% | -2.47% | -61.61% | -3.63% | -9.70% | 25.79% | -12.36% | -3.33% | -3.91% | -2.35% | 37.93% | -68.10% |
| 2021 | 2.73% | 13.81% | 9.89% | 11.74% | 21.32% | 27.83% | 10.14% | -1.88% | -63.46% | 75.85% | 7.89% | 1.73% | 69.64% |
| 2020 | 7.09% | 3.31% | -9.49% | -4.39% | 144.89% | 6.84% | -10.93% | 42.40% | -12.72% | -3.07% | 27.49% | -16.56% | 185.96% |
| 2019 | 21.10% | -1.60% | 56.73% | -17.82% | -2.61% | 20.38% | -9.00% | 18.24% | -7.83% | 11.99% | -35.32% | -18.97% | 4.75% |
| 2018 | 9.90% | -25.85% | -49.32% | 0.58% | -15.74% | -7.69% | 2.98% | 39.16% | 6.85% | -22.35% | -19.02% | 4.02% | -67.64% |
| 2017 | -17.96% | -23.17% | -7.58% | -21.00% | 10.38% | 1.25% | 7.78% | 33.96% | 8.21% | -15.28% | 30.26% | 6.67% | -5.41% |
| 2016 | 2.65% | 75.94% | -11.03% | 32.71% | -11.86% | 87.95% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PTGX is 71, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Protagonist Therapeutics Inc (PTGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Protagonist Therapeutics Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Protagonist Therapeutics Inc was 85.79%, occurring on Jun 13, 2022. The portfolio has not yet recovered.
The current Protagonist Therapeutics Inc drawdown is 22.46%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -85.79% | Sep 2, 2021 | 196 | Jun 13, 2022 | — | — | — |
| -82.13% | Dec 6, 2016 | 753 | Dec 3, 2019 | 302 | Feb 16, 2021 | 1055 |
| -20.33% | Oct 18, 2016 | 11 | Nov 1, 2016 | 7 | Nov 10, 2016 | 18 |
| -19.04% | Mar 22, 2021 | 6 | Mar 29, 2021 | 35 | May 18, 2021 | 41 |
| -12.77% | Feb 17, 2021 | 8 | Feb 26, 2021 | 2 | Mar 2, 2021 | 10 |
Volatility
Volatility Chart
The current Protagonist Therapeutics Inc volatility is 10.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Protagonist Therapeutics Inc compared to its peers in the Biotechnology industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for PTGX in comparison to other companies of the Biotechnology industry. Currently, PTGX has a PE value of 14.1. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for PTGX in comparison to other companies of the Biotechnology industry. Currently, PTGX has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Protagonist Therapeutics Inc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |